Radiation recall is an unpredictable, poorly understood inflammatory reaction within the confines of previously irradiated tissue that occurs following exposure to a systemic agent. In this article, we will focus on a subcategory of radiation recall, called radiation recall pneumonitis (RRP), precipitated by immune checkpoint inhibitors (ICI). Historically, RRP can develop weeks to years after radiation treatment to the lung, most commonly after receiving certain chemotherapeutic agents, but more recently has been recognized in association with immunotherapy agents (ICIs). Up until now, RRP following exposure to ICIs has been described in patients who have received radiation to the lung itself. Here we present three cases of RRP in patients who received radiation to areas adjacent to the lung parenchyma, and developed pulmonary infiltrates in an area adjacent to the radiation field while on ICI therapy. Since ICI induced RRP is treatable and steroid sensitive, early recognition and treatment are important.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507574PMC
http://dx.doi.org/10.1002/rcr2.1223DOI Listing

Publication Analysis

Top Keywords

radiation recall
16
radiation
9
recall pneumonitis
8
immune checkpoint
8
checkpoint inhibitors
8
patients received
8
received radiation
8
rrp
5
pneumonitis immune
4
inhibitors extra
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!